Megan’s career has spanned the pharmaceutical industry, translational research and investigator-initiated clinical trials.
Megan commenced her career in new product development at CSL Limited, then pursued a career in translational research with completion of a PhD at the Department of Immunology, University of Melbourne, and a subsequent post doctoral position at The Ludwig Cancer Institute, Melbourne, studying CD8+ T cell vaccines. Megan then returned to drug development, briefly working at Medicines Development Limited on HIV and coeliac disease clinical trials, before commencing with the ALLG.
Previously Megan held the newly established Protocol Development Coordinator role at the ALLG, where she was responsible for coordinating the development of more than 20 ALLG clinical trial protocols spanning all disease areas. Megan currently holds the role of Program Manager at the ALLG, where she is responsible for establishing and managing the ALLG Trial Centre and managing the programme of upcoming clinical trials that will be run through the ALLG Trial Centre.